The SNACC members agree that prolonged use of high-dose -adrenergic agonists may reduce perfusion of the optic nerve in high-risk patients; the consultants are equivocal, and the NANOS and NASS members report no opinion.
The SNACCmembers agree that prolonged use of high-dose -adrenergicagonists may reduce perfusion of the optic nerve in high-riskpatients; the consultants are equivocal, and the NANOS andNASS members report no opinion.